Search

Your search keyword '"Illicit Drugs chemistry"' showing total 697 results

Search Constraints

Start Over You searched for: Descriptor "Illicit Drugs chemistry" Remove constraint Descriptor: "Illicit Drugs chemistry"
697 results on '"Illicit Drugs chemistry"'

Search Results

1. Classics in Chemical Neuroscience: Medetomidine.

2. Emergence of semi-synthetic cannabinoids in cannabis products seized in Eastern Denmark over a 6-year period.

3. Barbie drug identification: Not a child's play.

4. The quantitative and qualitative analysis of dye in fentanyl tablets via ultraviolet-visible spectroscopy-A forensic approach.

5. Feature-Based Molecular Network for New Psychoactive Substance Identification: The Case of Synthetic Cannabinoids in a Seized e-Liquid and Biological Samples.

6. Identification of three unexpected new psychoactive substances at an Australian drug checking service.

7. Quantitative analysis of tetrahydrocannabinol isomers and other toxicologically relevant drugs in blood.

8. Challenges encountered in the enantioselective analysis of new psychoactive substances exemplified by clephedrone (4-CMC).

9. Log D 7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity.

10. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists.

11. Detection of N-desethyl etonitazene in a drug checking sample: Chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole "nitazene" class.

12. Chromatographic enantioresolution and stereochemical characterization of synthetic cannabinoid receptor agonists with Whelk-O®1 chiral stationary phases under mass spectrometry compatible reversed-phase conditions: A study case with seized samples.

13. Detection of the synthetic cathinone N,N-dimethylpentylone in seized samples from prisons.

14. Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021.

15. A systematic approach to the analysis of illicit drugs for DNA with an overview of the problems encountered.

16. Characterization of 17 unknown ketamine manufacturing by-product impurities by UHPLC-QTOF-MS.

17. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.

18. Amphetamine-like substances and synthetic cathinones in Portuguese wastewater influents: Enantiomeric profiling and role of suspended particulate matter.

19. Assessment of a Single Quadrupole Mass Spectrometer Combined with an Atmospheric Solids Analysis Probe for the On-Site Identification of Amnesty Bin Drugs.

20. Qualitative transformations of street-seized ecstasy over a decade: A case study in Rio de Janeiro (Brazil).

21. Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health.

22. Differentiating Structurally Similar Fentanyl Analogs by Comparing Density Functional Theory (DFT) Calculations and Surface-Enhanced Raman Spectroscopy (SERS) Results.

23. What's in drugs freely used by Brazilian truck drivers - "Rebites"? Determination of target and nontarget compounds by high-resolution mass spectrometry and nuclear magnetic resonance.

24. Fiber Laser-Generated Silver-109 Nanoparticles for Laser Desorption/Ionization Mass Spectrometry of Illicit Drugs.

25. Isolation and characterization of reference standard candidates for cocaine and benzoylecgonine obtained from illicit substances seized.

26. New materials used for the synthesis of 2-chlorophenyl cyclopentyl ketone seized from an illicit ketamine manufacturing unit.

27. Human metabolism and basic pharmacokinetic evaluation of AP-238: A recently emerged acylpiperazine opioid.

28. Real or fake? Sourcing and marketing of non-prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia.

29. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography-Ion Trap Mass Spectrometry Using a Simplified User Interface.

30. A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances.

32. Linking in vitro and ex vivo CB 1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites.

33. Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs.

34. Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists.

35. Characterization of new psychoactive substances by integrating benchtop NMR to multi-technique databases.

36. Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.

37. Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers.

38. Identification of the polymer-bounded drugs on the fabric surface: A challenge to the forensic drug analysts.

39. Comparison of Illicit Drug Seizures Products of Natural Origin Using a Molecular Networking Approach.

40. Quantification of mixtures of analogues of illicit substances by benchtop NMR spectroscopy.

41. Time-Series Analysis of Fentanyl Concentration in the Unregulated Opioid Drug Supply in a Canadian Setting.

43. Impurity profiling of methamphetamine synthesised from α-phenylacetoacetonitrile (APAAN).

44. Gas Chromatographic Fingerprint Analysis for the Comparison of Seized Cannabis Samples.

45. Comparative analysis of vapor profiles of fentalogs and illicit fentanyl.

46. Analytical characterization of "etonitazepyne," a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online.

47. An updated review on synthetic cathinones.

48. Application of a Low Transition Temperature Mixture for the Dispersive Liquid-Liquid Microextraction of Illicit Drugs from Urine Samples.

49. Screening sexual performance enhancing compounds and their analogues in counterfeit and illicit erectile dysfunction drugs by high-performance liquid chromatography and liquid chromatography-tandem mass spectrometry.

50. A comprehensive study on the performance of different retention mechanisms in sport drug testing by liquid chromatography tandem mass spectrometry.

Catalog

Books, media, physical & digital resources